Literature DB >> 18508313

Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma.

Yan Ru Qin1, Li Fu, Pak C Sham, Dora L W Kwong, Cai Lei Zhu, Kevin K W Chu, Yan Li, Xin-Yuan Guan.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common solid tumors in the world with poor prognosis. Deletion of chromosome 3p is one of the most frequent chromosomal alterations in ESCC, suggesting the existence of one or more tumor suppressor genes (TSGs) at this region. In the present study, a recently developed high-throughput and high-resolution technology, single-nucleotide polymorphism (SNP)-mass array, was applied to investigate loss of heterozygosity on 3p in 100 primary ESCC cases with 386 SNP markers. Four commonly deleted regions (CDRs) at 3p26.3, 3p22, 3p21.3 and 3p14.2 were identified. Absent and down-regulated expression of several candidate TSGs, including CHL1, PCAF, RBMS3, PLCD1 and CACNA2D3, were detected in primary ESCC tumors and ESCC cell lines. Moreover, deletions of CDRs 2 and 4 were correlated with advanced tumor stage and deletion of CDR2 was associated with tumor metastasis in ESCC. Our findings provided evidence that minimal deleted regions at 3p26.3, 3p22, 3p21.3 and 3p14.2 containing potential TSGs may contribute to the pathogenesis of esophageal cancer. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508313     DOI: 10.1002/ijc.23577

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Genetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivity.

Authors:  Joseph C Maranville; Shaneen S Baxter; David B Witonsky; Meredith A Chase; Anna Di Rienzo
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

2.  Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.

Authors:  Hong Tang; Lingxi Jiang; Cailei Zhu; Raymond Liu; Yufeng Wu; Qian Yan; Ming Liu; Yongxu Jia; Juan Chen; Yanru Qin; Victor Ho-Fun Lee; Suxia Luo; Qiming Wang; Xin-Yuan Guan
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

3.  Method to detect differentially methylated loci with case-control designs using Illumina arrays.

Authors:  Shuang Wang
Journal:  Genet Epidemiol       Date:  2011-08-04       Impact factor: 2.135

4.  Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.

Authors:  Wan-Ting Huang; Shao-Wen Weng; Yu-Ching Wei; Huey-Ling You; Jui-Tzu Wang; Hock-Liew Eng
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Authors:  Naoimh Herlihy; Mehmet Dogrusöz; T Huibertus van Essen; J William Harbour; Pieter A van der Velden; Marja C J A van Eggermond; Geert W Haasnoot; Peter J van den Elsen; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-15       Impact factor: 4.799

6.  Tumor Suppressor Effect of RBMS3 in Breast Cancer.

Authors:  Chunyang Wang; Yidan Wu; Yunqi Liu; Fushun Pan; Huijuan Zeng; Xiaoxi Li; Liang Yu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  Alopecia in a viable phospholipase C delta 1 and phospholipase C delta 3 double mutant.

Authors:  Fabian Runkel; Maik Hintze; Sebastian Griesing; Marion Michels; Birgit Blanck; Kiyoko Fukami; Jean-Louis Guénet; Thomas Franz
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 8.  Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.

Authors:  Juan Chen; Li Fu; Li-Yi Zhang; Dora L Kwong; Li Yan; Xin-Yuan Guan
Journal:  Chin J Cancer       Date:  2012-02-24

9.  RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis.

Authors:  Juan Chen; Dora Lai-Wan Kwong; Cai-Lei Zhu; Lei-Lei Chen; Sui-Sui Dong; Li-Yi Zhang; Jun Tian; Chu-Bo Qi; Ting-Ting Cao; Alissa Michelle Go Wong; Kar-Lok Kong; Yan Li; Ming Liu; Li Fu; Xin-Yuan Guan
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma.

Authors:  Yan Li; Cai-Lei Zhu; Chang-Jun Nie; Jiang-Chao Li; Ting-ting Zeng; Jie Zhou; Jinna Chen; Kai Chen; Li Fu; Haibo Liu; Yanru Qin; Xin-Yuan Guan
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.